(IBTO) iShares iBonds Dec 2033 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E1486

IBTO: U.S. Treasury, Target Maturity, ETF, Bonds

The iShares iBonds Dec2033 Term Treasury ETF is a targeted maturity ETF that invests at least 80% of its assets in the component securities of its underlying index, with a focus on U.S. Treasury securities to track the indexs performance. As the fund approaches its maturity date, its investment strategy remains focused on mirroring the underlying index.

Given its investment objective, the ETF is designed to provide investors with exposure to a specific segment of the U.S. Treasury market, maturing in December 2033. The funds asset allocation is centered around U.S. Treasury securities, which are generally considered to be low-risk investments. The ETFs management team, led by BlackRocks BFA, employs a passive management approach to track the underlying index, ensuring that the funds performance is closely aligned with that of the index.

Analyzing the ETFs recent price action, we observe a relatively stable trend, with the last price recorded at $24.15. The short-term and medium-term moving averages (SMA20 and SMA50) are $24.19 and $24.15, respectively, indicating a stable price trajectory. The longer-term SMA200 stands at $23.89, suggesting a slightly bullish trend over the past year. The Average True Range (ATR) of 0.17, or 0.72%, indicates moderate daily price volatility.

Considering the ETFs AUM of $336.06M USD, it appears to have a reasonable level of liquidity. As the fund approaches its maturity date, investors can expect the ETFs duration to decrease, potentially leading to reduced volatility. Based on the current technical and fundamental data, a forecast for the ETFs price trajectory suggests that it may continue to track the underlying index closely, with potential for slight price appreciation as the funds maturity date approaches. A possible price target could be around $25.00, assuming a stable interest rate environment and continued demand for U.S. Treasury securities.

Additional Sources for IBTO ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

IBTO ETF Overview

Market Cap in USD 342m
Category Target Maturity
TER 0.07%
IPO / Inception 2023-06-27

IBTO ETF Ratings

Growth Rating 24.8
Fundamental -
Dividend Rating 58.3
Rel. Strength -7.87
Analysts -
Fair Price Momentum 24.28 USD
Fair Price DCF -

IBTO Dividends

Dividend Yield 12m 4.13%
Yield on Cost 5y 4.33%
Annual Growth 5y 55.68%
Payout Consistency 100.0%
Payout Ratio %

IBTO Growth Ratios

Growth Correlation 3m 10.1%
Growth Correlation 12m 24.4%
Growth Correlation 5y 78.5%
CAGR 5y 2.96%
CAGR/Max DD 5y 0.35
Sharpe Ratio 12m 0.47
Alpha 1.96
Beta -0.074
Volatility 6.19%
Current Volume 76k
Average Volume 20d 36.2k
What is the price of IBTO shares?
As of June 29, 2025, the stock is trading at USD 24.42 with a total of 75,985 shares traded.
Over the past week, the price has changed by +0.91%, over one month by +1.66%, over three months by +2.26% and over the past year by +5.44%.
Is iShares iBonds Dec 2033 a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares iBonds Dec 2033 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.84 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTO is around 24.28 USD . This means that IBTO is currently overvalued and has a potential downside of -0.57%.
Is IBTO a buy, sell or hold?
iShares iBonds Dec 2033 has no consensus analysts rating.
What are the forecasts for IBTO share price target?
According to our own proprietary Forecast Model, IBTO iShares iBonds Dec 2033 will be worth about 26.2 in June 2026. The stock is currently trading at 24.42. This means that the stock has a potential upside of +7.37%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.2 7.4%